Fluticasone Propionate

API Product
Fluticasone Propionate | Hovione
Product Status:
Commercial
Available Grades:
  • Inhalation
  • Micronized
  • Non-Micronized
Regulatory Status:
Korean DMF
CN DMF
JP DMF
US DMF
CEP
Production Sites:
  • Hovione Loures
Product Type:
  • Corticosteroids
CAS Number:
80474-14-2
Modes of Application:
  • Topical
  • Inhalation
  • Nasal
Common Indications:
  • Allergic rhinitis
  • Asthma
Last Inspection:
FDA May 2018

Hovione can customize Fluticasone propionate for inhalation with an unrivalled range of particle size reduction technologies for the production of tailor made API, featuring a near-perfect particle size distribution reproducibility with a low span and amorphous content, providing highly stable API.

Hovione Fluticasone Propionate is available since 2001 and is approved in branded, generic and 505b2 applications.

With a proven track record in developing and manufacturing high performance APIs Hovione offers a full range of API for inhalation, e.g. Salmeterol Xinafoate.

 

 


This is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties' patent rights.

Highlight

Contact Us

Please contact us if you have inquiries about our offering

https://go.hovione.com/l/47122/2014-08-06/9grc

Related files

Hovione - Integrated Product List
pdf (3.23 MB)
Download

Related Content

Continuous Tableting for Drug Product

Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.

Page
Read more

60 Years

In 2019, Hovione celebrates its 60th Anniversary.

Page
Read more

Drug Product Development

Leveraging our expertise particle engineering, Hovione can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more